Ask AI
ProCE Banner Series

Optimizing Multidisciplinary Care of Immunotherapy-Eligible Patients With Newly Diagnosed Advanced NSCLC: Strategies for Rural and Community Practices

Join oncology experts Ticiana Leal, MD, and Jamie E. Chaft, MD, for interactive workshops on integrating immunotherapy into rural and community oncology practice for patients with NSCLC.

  AAPA
  | ACPE
  | AMA
  | ANCC
Who Should Attend

This activity is intended for oncologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with newly diagnosed advanced/metastatic NSCLC in rural community cancer practices.

Additional Info

There are no fees required to participate in this activity.

Americans With Disabilities Act
Event staff will be glad to assist you with any special needs (eg, physical, dietary). Please contact Customer Support prior to the live event.

CME/CE Info

Goal Statement
This activity aims to elevate learners' knowledge, confidence, and competence at aligning rural cancer care with recent data and best practices to optimize the clinical outcomes of each patient with advanced/metastatic NSCLC eligible for immunotherapy-based treatment.

Target Audience
This activity is intended for oncologists, nurse practitioners, physician associates, nurses, pharmacists, and other healthcare professionals caring for patients with newly diagnosed advanced/metastatic NSCLC in rural community cancer practices.

Learning Objectives
Upon completion of this activity, participants should be able to:

  • Identify patients with newly diagnosed advanced/metastatic NSCLC at risk for health inequities due to access to care, race/ethnicity, age, or other sociodemographic factors

  • Implement best practices in molecular testing and interpreting results to identify every patient with newly diagnosed advanced/metastatic NSCLC eligible for immunotherapy

  • Collaborate with each patient and the multidisciplinary team to personalize an immunotherapy-based treatment plan for newly diagnosed advanced/metastatic NSCLC with consideration for the latest data, expert recommendations, and patient preferences

  • Educate all eligible patients and their caregivers on the risk–benefit profile and goals of immunotherapy-based treatment using effective communication strategies and resources

  • Manage immune-related adverse events associated with immunotherapy-based treatments to maximize quality of life and clinical outcomes in each patient with newly diagnosed advanced/metastatic NSCLC

Accreditation

Joint Accreditation Statement

In support of improving patient care, Clinical Care Options, LLC (CCO) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physician Continuing Medical Education

CCO designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Professional Development

The maximum number of hours awarded for this Nursing Continuing Professional Development activity is 1.0 contact hour.

Continuing Pharmacy Education

CCO designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education. Universal Activity Number: Specific to each event 

Type of Activity: Application

Upon successfully completing the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 60 days.

Physician Associate Continuing Medical Education

Clinical Care Options, LLC has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credits. PAs should only claim commensurate with the extent of their participation.

American Board of Internal Medicine Maintenance of Certification

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.0 MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

For ABIM MOC points, your information will be shared with the ABIM through CCO's Joint Accreditation Program and Activity Reporting System (JAPARS). Please allow 6-8 weeks for your MOC points to appear on your ABIM records.

By sharing your Diplomate Board ID # and DOB, you are giving Clinical Care Options, LLC permission to use this information/data to report your participation to these Boards via the Joint Accreditation Program and Activity Reporting System (JA-PARS).

CME for MIPS

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/645130bfd42f3.png

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS).

In order to fulfill requirements for MIPS improvement activity, participants will need to fill out 2 brief follow-up surveys at 30- and 90-days post-activity.

CME Passport

https://omni-channel-2022-assets-production.s3.amazonaws.com/editorupload/662be69741e7b.png

The CME credits that physicians earn from this activity will be submitted to ACCME's CME Passport, a free, centralized web application where you can create a personalized account to view, track, and generate transcripts of your reported CME credit. Visit www.cmepassport.org to create your account.

Disclosure of Conflicts of Interest
Clinical Care Options, LLC (CCO) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all financial conflicts of interest (COI) they may have with ineligible companies. All relevant COI are thoroughly vetted and mitigated according to CCO policy. CCO is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

Acknowledgement

Provided by

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC

Supporters

Supported by an educational grant from Merck Sharp & Dohme LLC.

Merck Sharp & Dohme, LLC

For customer support please click here.

Mailing Address:

 

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 304
Reston, VA 20191